Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country

Published:2016 Issue:43 Volume:22 Page:9613
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Hlaing Naomi Khaing Than,Banerjee Debolina,Mitrani Robert,Arker Soe Htet,Win Kyaw San,Tun Nyan Lin,Thant Zaw,Win Khin Maung,Reddy K Rajender

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference21 articles.

1. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

2. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives

3. New treatments for HCV: Perspective from Asia

4. Sustained Virologic Response to a Dual Peginterferon alfa-2a and Ribavirin in Treating Chronic hepatitis C Infection

5. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pegylated interferon and ribavirin gone but not forgotten in the era of direct-acting antivirals;Minerva Pediatrics;2022-03

2. Guanosine inhibits hepatitis C virus replication and increases indel frequencies, associated with altered intracellular nucleotide pools;PLOS Pathogens;2022-01-27

3. Guanosine inhibits hepatitis C virus replication and increases indel frequencies, associated with altered intracellular nucleotide pools;2020-02-24

4. High sustained virologic response in genotypes 3 and 6 with generic NS5A inhibitor and sofosbuvir regimens in chronic HCV in myanmar;Journal of Viral Hepatitis;2019-06-10

5. Strategy and Efficacy of Generic and Pan-genotypic Sofosbuvir/Velpatasvir in Chronic Hepatitis C Virus: A Myanmar Experience;Journal of Clinical and Experimental Hepatology;2019-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3